Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LASN-01 by Lassen Therapeutics 1 for Graves' Ophthalmopathy: Likelihood of Approval
LASN-01 is under clinical development by Lassen Therapeutics 1 and currently in Phase II for Graves' Ophthalmopathy. According to GlobalData,...
LASN-01 by Lassen Therapeutics 1 for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
LASN-01 is under clinical development by Lassen Therapeutics 1 and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to...
LASN-01 by Lassen Therapeutics 1 for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease): Likelihood of Approval
LASN-01 is under clinical development by Lassen Therapeutics 1 and currently in Phase II for Interstitial Lung Diseases (Diffuse Parenchymal...